A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT03677141 · COMPLETED
Trial details
- NCT number
- NCT03677141
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2023-10-12
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.